David Slack
Directeur Général chez Cend Therapeutics, Inc.
Fortune : 7 767 $ au 31/05/2024
Postes actifs de David Slack
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/10/2019 | - |
| Directeur Général | 08/07/2020 | - | |
| President | 08/07/2020 | - | |
| Lisata Therapeutics Australia Pty Ltd. | Président | - | - |
Historique de carrière de David Slack
Anciens postes connus de David Slack
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LISATA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/09/2022 | 01/05/2023 |
| President | 15/09/2022 | 01/05/2023 | |
| DS Lifescience Consulting | Corporate Officer/Principal | 01/01/2004 | 01/03/2021 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Corporate Officer/Principal | 01/08/2016 | 01/07/2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2004 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
Formation de David Slack
| California State University-Sacramento | Undergraduate Degree |
| Monterey Institute of International Studies | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 10 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 2 |
| President | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LISATA THERAPEUTICS, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
| Lisata Therapeutics Australia Pty Ltd. | |
| DS Lifescience Consulting | |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bourse
- Insiders
- David Slack
- Expérience
